Genelex

New Look, New Brand, and New Pharmacists

After more than a decade, the medical and insurance communities are beginning to embrace DNA-based analysis as a powerful tool in selecting and optimizing pharmaceutical treatments. Genelex has been a consistent front-runner in these technologies.

GeneMedRx and our drug sensitivity tests are combining under our new YouScript™ brand. Over the next few months, you’ll notice changes in our informational materials and a major upgrade to our services.

Tyler Mamiya & Paul Verbeurgt  

For those who haven’t taken advantage of GeneMedRx, our new YouScript™ Personalized Prescribing System is a comprehensive, long-term solution for safer, more targeted prescribing. Most patients taking a series of drugs have genetic variations that affect their ability to process those drugs – to either eliminate or activate them. This includes most classes of routinely prescribed drugs, over-the-counter medicines, many herbal preparations, and some dietary supplements and foods. Cytochrome P450 testing detects those genetic variations.

Now, whenever a major or significant drug-drug or drug-gene interaction risk is noted, YouScript™ will generate a medication advisory report including potential alternative drug or dosing recommendations based on the patient’s DNA test results and overall medication regimen.

To bring more clarity to the prescribing process, we have a new team of clinical pharmacists: Paul Verbeurgt and Tyler Mamiya. They are busy analyzing patient medication regimens, DNA test results, and recommending specific actions to help improve prescribing outcomes. They are available to help prescribers, patients, and other pharmacists understand specific cases and to guide users in getting the most out of the YouScript™

system.

We’re celebrating the evolution of our state-of-the-art personalized prescribing services. We encourage you to join in the excitement, and the opportunity to improve patient care, by taking advantage of our new services today!